Allmed Solutions Ltd (ALMD.TA)
ILA 36.8
(-0.54%)
ILA 36.8
(-0.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 7.13 Million | -10.21 Million | -5.47 Million | -8.81 Million | -12.32 Million | -16.02 Million |
| Net Income | 1.42 Million | -12.14 Million | 2.7 Million | -9.24 Million | 21.38 Million | -20.48 Million |
| Depreciation & Amortization | 476 Thousand | 550 Thousand | 1.06 Million | 1.85 Million | 2.67 Million | 1.99 Million |
| Deferred income taxes | 5.98 Million | - | -13.1 Million | -2.39 Million | -41.01 Million | 74 Thousand |
| Stock-based compensation | 419 Thousand | 1.57 Million | 2.14 Million | 1.44 Million | 1.44 Million | 4.39 Million |
| Change in working capital | -74 Thousand | 135 Thousand | 620 Thousand | -1.14 Million | 2.68 Million | 608 Thousand |
| Other non-cash items | -1.08 Million | -335 Thousand | 1.09 Million | 679 Thousand | 502 Thousand | -2.6 Million |
| Investing Cash Flow | -21.59 Million | 2.18 Million | 12.54 Million | 6.05 Million | 20.13 Million | 5.8 Million |
| Investments in PPE | -119 Thousand | -438 Thousand | -44 Thousand | -130 Thousand | -80 Thousand | -207 Thousand |
| Acquisitions | 2.84 Million | 2.62 Million | 12.58 Million | -290.00 | 12.75 Million | - |
| Investment purchases | -50.71 Million | -5.24 Million | - | 290.00 | -187 Thousand | - |
| Sales/Maturities of investments | - | 2.62 Million | - | 5.11 Million | 9 Million | 6 Million |
| Other Investing Activities | 26.38 Million | 2.62 Million | -981.00 | 1.06 Million | -1.35 Million | 5.99 Million |
| Financing Cash Flow | -288 Thousand | 12.01 Million | -539 Thousand | -1.5 Million | -541 Thousand | 9.96 Million |
| Debt repayment | -288.00 | -372 Thousand | -724 Thousand | -1.22 Million | -1.17 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 12.38 Million | 344 Thousand | - | 925 Thousand | 10.2 Million |
| Other Financing Activities | -288 Thousand | 12.01 Million | -159 Thousand | -280 Thousand | -291 Thousand | -242 Thousand |
| Accounts receivables | 431.00 | -716 Thousand | -371 Thousand | 242 Thousand | 1.43 Million | 724 Thousand |
| Accounts payables | - | - | 371 Thousand | -242 Thousand | -1.43 Million | - |
| Inventory | - | - | 12 Thousand | -281 Thousand | 910 Thousand | -277 Thousand |
| Other working capital | -431.00 | 851 Thousand | 608 Thousand | -868 Thousand | 1.77 Million | 885 Thousand |
| Cash at beginning of period | 21.03 Million | 15.6 Million | 9.93 Million | 14.74 Million | 7.75 Million | 7.94 Million |
| Cash at end of period | 6.67 Million | 21.03 Million | 15.6 Million | 9.93 Million | 14.74 Million | 7.75 Million |
| Capital Expenditure | -119 Thousand | -438 Thousand | -44 Thousand | -130 Thousand | -80 Thousand | -207 Thousand |
| Effect of forex changes on cash | 392 Thousand | 1.44 Million | -860 Thousand | -531 Thousand | -282 Thousand | 71 Thousand |
| Net cash flow / Change in cash | -14.35 Million | 5.42 Million | 5.66 Million | -4.8 Million | 6.98 Million | -188 Thousand |
| Free Cash Flow | 7.01 Million | -10.65 Million | -5.52 Million | -8.94 Million | -12.4 Million | -16.23 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1692.00 | -1692.00 | 1.42 Million | -5091.00 | -5091.00 | 5802.00 |
| Depreciation & Amortization | 136.50 | 136.50 | 476 Thousand | 118.00 | 118.00 | 120.00 |
| Deferred income taxes | - | - | 5.98 Million | - | - | -462 Thousand |
| Stock-based compensation | 88.00 | 88.00 | 419 Thousand | 60.50 | 60.50 | 149.00 |
| Change in working capital | -48.50 | -48.50 | -74 Thousand | -114.00 | -114.00 | 114.00 |
| Other non-cash items | -489.00 | -489.00 | -1.08 Million | 3205.00 | 3205.00 | -795.50 |
| Investing Cash Flow | 3635.00 | 3635.00 | -21.59 Million | -10.51 Thousand | -10.51 Thousand | -284.00 |
| Investments in PPE | -13.50 | -13.50 | -119 Thousand | -13.00 | -13.00 | -46.50 |
| Acquisitions | - | - | 2.84 Million | 157.50 | 157.50 | -157.50 |
| Investment purchases | - | - | -50.71 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3648.50 | 3648.50 | 26.38 Million | -10.65 Thousand | -10.65 Thousand | -80.00 |
| Financing Cash Flow | -2829.00 | -2829.00 | -288 Thousand | -78.00 | -78.00 | -66.00 |
| Debt repayment | - | - | -288.00 | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2747.00 | -2747.00 | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -82.00 | -82.00 | - | -78.00 | -78.00 | -66.00 |
| Accounts receivables | -35.00 | -35.00 | 431.00 | -73.50 | -73.50 | 289.00 |
| Accounts payables | - | - | - | - | - | -411 Thousand |
| Inventory | - | - | - | - | - | 761 Thousand |
| Other working capital | -13.50 | -13.50 | -431.00 | -40.50 | -40.50 | -175.00 |
| Cash at beginning of period | - | - | 21.03 Million | - | - | 23.69 Million |
| Cash at end of period | -1110.00 | -1110.00 | 6.67 Million | -12.41 Thousand | -12.41 Thousand | 31.51 Million |
| Capital Expenditure | -13.50 | -13.50 | -119 Thousand | -13.00 | -13.00 | -46.50 |
| Effect of forex changes on cash | 89.00 | 89.00 | 392 Thousand | -4.00 | -4.00 | 200.00 |
| Net cash flow / Change in cash | -1110.00 | -1110.00 | -14.35 Million | -12.41 Thousand | -12.41 Thousand | 7.81 Million |
| Free Cash Flow | -2018.50 | -2018.50 | 7.01 Million | -1834.50 | -1834.50 | 5343.00 |
2915
3317
FGT
2102
BEBE
BGFD